Oral Poliovirus Vaccine Evolution and Insights Relevant to Modeling the Risks of Circulating Vaccine-Derived Polioviruses (cVDPVs)-Reference-Cited by-同舟云学术

Oral Poliovirus Vaccine Evolution and Insights Relevant to Modeling the Risks of Circulating Vaccine-Derived Polioviruses (cVDPVs)

Published:2013-03-07 Issue:4 Volume:33 Page:680-702
ISSN:0272-4332
Container-title:Risk Analysis
language:en
Short-container-title:Risk Analysis

Author:

Duintjer Tebbens Radboud J.¹,Pallansch Mark A.²,Kim Jong-Hoon¹,Burns Cara C.²,Kew Olen M.²,Oberste M. Steven²,Diop Ousmane M.³,Wassilak Steven G.F.⁴,Cochi Stephen L.⁴,Thompson Kimberly M.

Affiliation:

1. Kid Risk, Inc.; 10524 Moss Park Rd., Ste.; 204-364; Orlando; FL; USA

2. Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases; Division of Viral Diseases; Atlanta; GA; USA

3. World Health Organization; Global Polio Eradication Initiative; Geneva; Switzerland

4. Centers for Disease Control and Prevention, Center for Global Health; Global Immunization Division; Atlanta; GA; USA

Publisher

Wiley

Subject

Physiology (medical),Safety, Risk, Reliability and Quality

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/risa.12022/fullpdf

Reference145 articles.

1. Poliovirus vaccine-live

2. Requirements for persistent immunity to poliomyelitis;Salk;American Journal of Medical Science,1956

3. Possible protective effect of previous type 2 infection against paralytic poliomyelitis due to type 1 virus;Hammon;American Journal of Hygiene,1957

4. Seroprevalence of antibody against poliovirus in inner-city preschool children;Chen;Journal of the American Medical Association,1996

5. Lesson from Cuba: Mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies;Más Lago;Bulletin of the World Health Organization,1994

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution of global polio eradication strategies: targets, vaccines, and supplemental immunization activities (SIAs);Expert Review of Vaccines;2024-06-07

2. Modeling the spread of circulating vaccine-derived poliovirus type 2 outbreaks and interventions: A case study of Nigeria;Vaccine: X;2024-06

3. Trade-offs of different poliovirus vaccine options for outbreak response in the United States and other countries that only use inactivated poliovirus vaccine (IPV) in routine immunization;Vaccine;2024-02

4. Oral polio vaccine stockpile modeling: insights from recent experience;Expert Review of Vaccines;2023-09-29

5. Rapid emergence and transmission of virulence-associated mutations in the oral poliovirus vaccine following vaccination campaigns;npj Vaccines;2023-09-25